LeeLemonoil
Member
- Joined
- Sep 24, 2016
- Messages
- 4,265
The researchers tried to figure out the effects of oral ß-Ecdysterone on the skin of female only rats, becuase they wanted to see if ß-Ecdy might be a supplement for menopausal women that, according to their thinking, experience accelerated skin-aging due to loss of Estradiol/E2.
They used ovariectomized (OVX) rats to simulate for postmenopausal state. They also had an "intact" (ovaries not removed) group, one to be supplemented with E2 and 3 fo various dosages of Ecdysterone.
Skin parameters studied were:
Thickness epiermal layer - Thickness dermal layer - Thickness subcutaneous fat layer - Thickness subcutaneous muscle layer
from the study:
Results:
Epidermal thickness was lowest in the OVX animals, slightly higher in the E2-treated animals, and significantly higher in the Ecd-treated animals. Dermal thickness was lowest in the intact and E2-treated animals and highest in the Ecd-treated animals. The subcutaneous fat layer was thickest in the OVX animals, thinner in the intact animals, and intermediate in the Ecd-treated animals. The muscle layer was smallest in the OVX and intact animals and significantly larger in the E2- and Ecd-treated animals. The number of proliferating cell nuclear antigen antibody-positive cells was lowest in OVX controls and significantly higher in all other groups.
Conclusions:The Ecd-induced increases in epidermal and dermal thickness are suggestive of functional changes of the skin. The decreased amounts of subcutaneous fat in the E2- and Ecd-treated animals point to either a fat catabolic or an antianabolic effect. The ovariectomy-induced decrease in subcutaneous musculature was prevented by Ecd but not by E2. The stimulatory effects of Ecd on epidermal and dermal thickness and the muscle-increasing effects in the skin of OVX rats may indicate functional changes
and :
Try ecdysteroids for younger skin and more muscle mass
with graphics
I find the results hard to interprete becuase Ecdysterone has for all 4 researched categories different effects to the other rat-states, sometimes hinting to a more "androgenic" sometimes possibly to an "estrogenic" canonical effect:
Epidermal thickness seems roughly the same in all rat-groups and is not so much a trait of aging skin anyway.
Dermal thickness though was higher in Ecdy-groups than in all others. Intriguingly, E2 group had the thinnest dermal thickness, even thinner than E2. Is this an anti-aging sign of E2 and would Ecdystrone thus accelerate skin-aging? (Dermal thickness maybe caused by unwanted collagenous tissue?). Or is ist vice versa?
Subcutaneous fat was clearly higher in OVX-rats and lowest in E2. This seems counterintuitive - or it means that OVX is highly pathological state with tendency for lipogenesis and that E2-treated rats have not such a drastic aging effect and retain normal or not overly reduced capacity of generating fat-layer. Some E2 is surely needed in female skin, male skin as well?
Ecdysterone had the thickest fat layer. Could be either abnormal/pathological or a real anti-age/rejuvenating effect.
Ecdysterone-groups had the thckst subcoutaneous muscle layer, hinting at more "andor" effects. E2 and OVX-groups were lowest. Subcutaneous muscle surely are beneficial?
The researchers themselves fail to come to a consistet conclusion, as stressed by the sentence in red. Why woud fat-reduction be antianabolic?
Pls share some ideas or how you interprete the effects of ß-Ecdysterone.
They used ovariectomized (OVX) rats to simulate for postmenopausal state. They also had an "intact" (ovaries not removed) group, one to be supplemented with E2 and 3 fo various dosages of Ecdysterone.
Skin parameters studied were:
Thickness epiermal layer - Thickness dermal layer - Thickness subcutaneous fat layer - Thickness subcutaneous muscle layer
from the study:
Results:
Epidermal thickness was lowest in the OVX animals, slightly higher in the E2-treated animals, and significantly higher in the Ecd-treated animals. Dermal thickness was lowest in the intact and E2-treated animals and highest in the Ecd-treated animals. The subcutaneous fat layer was thickest in the OVX animals, thinner in the intact animals, and intermediate in the Ecd-treated animals. The muscle layer was smallest in the OVX and intact animals and significantly larger in the E2- and Ecd-treated animals. The number of proliferating cell nuclear antigen antibody-positive cells was lowest in OVX controls and significantly higher in all other groups.
Conclusions:The Ecd-induced increases in epidermal and dermal thickness are suggestive of functional changes of the skin. The decreased amounts of subcutaneous fat in the E2- and Ecd-treated animals point to either a fat catabolic or an antianabolic effect. The ovariectomy-induced decrease in subcutaneous musculature was prevented by Ecd but not by E2. The stimulatory effects of Ecd on epidermal and dermal thickness and the muscle-increasing effects in the skin of OVX rats may indicate functional changes
and :
Try ecdysteroids for younger skin and more muscle mass
with graphics
I find the results hard to interprete becuase Ecdysterone has for all 4 researched categories different effects to the other rat-states, sometimes hinting to a more "androgenic" sometimes possibly to an "estrogenic" canonical effect:
Epidermal thickness seems roughly the same in all rat-groups and is not so much a trait of aging skin anyway.
Dermal thickness though was higher in Ecdy-groups than in all others. Intriguingly, E2 group had the thinnest dermal thickness, even thinner than E2. Is this an anti-aging sign of E2 and would Ecdystrone thus accelerate skin-aging? (Dermal thickness maybe caused by unwanted collagenous tissue?). Or is ist vice versa?
Subcutaneous fat was clearly higher in OVX-rats and lowest in E2. This seems counterintuitive - or it means that OVX is highly pathological state with tendency for lipogenesis and that E2-treated rats have not such a drastic aging effect and retain normal or not overly reduced capacity of generating fat-layer. Some E2 is surely needed in female skin, male skin as well?
Ecdysterone had the thickest fat layer. Could be either abnormal/pathological or a real anti-age/rejuvenating effect.
Ecdysterone-groups had the thckst subcoutaneous muscle layer, hinting at more "andor" effects. E2 and OVX-groups were lowest. Subcutaneous muscle surely are beneficial?
The researchers themselves fail to come to a consistet conclusion, as stressed by the sentence in red. Why woud fat-reduction be antianabolic?
Pls share some ideas or how you interprete the effects of ß-Ecdysterone.